Today, we announced that Pfizer completed the acquisition of Metsera, a strategic milestone representing our investment in the future of medicine. Learn more about Pfizer’s commitment to accelerating the next generation of treatment candidates for obesity and cardiometabolic disease: https://lnkd.in/e_Di8UHd
About us
We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines
- Website
-
https://www.pfizer.com/?source=Linkedin
External link for Pfizer
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- New York, New York
- Type
- Public Company
- Specialties
- To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.
Locations
Employees at Pfizer
Updates
-
⏳ Just a few days left! Are you a startup with a bold digital health idea? This is your chance to join CDI’s Start4Health, a 6-week acceleration journey where innovation meets healthcare. 💡Don’t miss the opportunity to gain mentorship, connect with industry experts, and pitch for prizes and potential future collaborations. 👉 Apply now before the deadline closes! https://lnkd.in/e2FYEyk5 #Pfizer #CDI #Start4Health #Innovation
-
-
Tune into #ThePowerofKnowing with Lidia Fonseca and Julie Sweet as they redefine bold leadership in tech, turning uncertainty into a launchpad for reinvention and growth.
Julie Sweet has been one of the most influential voices on how AI is reshaping business and leadership. As Chair and CEO of Accenture, she continues to challenge companies to rethink how they work in an AI-driven world. In the latest episode of #ThePowerofKnowing, I sat down with Julie to explore what leadership looks like in this new era of technology and how she views uncertainty not as a barrier, but as a launch pad for reinvention and opportunity. Julie’s insights remind me that success today is not about control or incremental change. It is about having the courage to dream big, to reimagine workflows from the ground up, and to see possibilities where others see risk. 🎥 Watch the full episode of #ThePowerofKnowing here: https://lnkd.in/eWDeSPvH #ThePowerofKnowing
-
#HealthAnswersbyPfizer––our AI-powered consumer digital experience that delivers personalized, trusted health information––is now available in Spanish!
I am proud to share a milestone that reflects Pfizer’s commitment to equity and access: #HealthAnswersbyPfizer is now available in Spanish! Health Answers by Pfizer is our consumer digital experience powered by generative AI that provides clear, relevant answers to your health and wellness questions. Now, it can serve over 40 million Spanish-speaking individuals in the U.S., offering answers in their preferred language. At Pfizer, we believe every person deserves to be seen, heard, and cared for. Expanding Health Answers by Pfizer is one way we live that value: by improving access and recognizing the needs of millions who navigate healthcare in a language that reflects their identity. Shared language builds trust. Trust drives better health outcomes. And access to clear, relevant information is foundational to both. What happens when we design with empathy and build for everyone? We create a future where care feels personal—and possible. Check out Health Answers by Pfizer in Spanish today: https://lnkd.in/eWxwe_w8 ¿Qué ocurre cuando diseñamos con empatía y creamos para todas las personas? Creamos un futuro en el que el cuidado se siente como algo personal y posible.
-
-
#BreakingNews: Today, Pfizer announced a landmark and voluntary agreement with the U.S. Government that lowers drug costs for Americans. With this agreement in place, we can invest even more boldly in the U.S. – fueling growth, creating jobs, returning manufacturing home, and continuing to advance our purpose: Breakthroughs that change patients' lives. Learn more about this announcement: https://lnkd.in/eCc3nYay
-
-
Learn what it takes to stay grounded, strengthen connections, and create the conditions where people can thrive in the midst of transformation with Lidia Fonseca and Arianna Huffington #ThePowerofKnowing
I am thrilled to launch the next episode of #ThePowerofKnowing! I had the privilege of speaking with the remarkable Arianna Huffington about how leadership, well-being, and technology intersect for the good of humanity. Our conversation explored what it takes to stay grounded, strengthen connections, and create the conditions where people can thrive in the midst of transformation. 🎥 Watch the full episode here: https://lnkd.in/erjd_rVJ #ThePowerofKnowing
-
We are proud to announce that Pfizer has reached a definitive agreement to acquire Metsera, a clinical-stage biopharmaceutical company. This acquisition will enhance our Internal Medicine portfolio and help us address the significant unmet needs in obesity and cardiometabolic disease. Obesity is a major global health challenge, contributing to chronic diseases, shortened lifespans, and rising healthcare costs. While GLP-1 medications have made strides, there is still a significant unmet need among patients with obesity and the more than 200 associated health conditions. Metsera brings a portfolio of promising therapeutic candidates, including clinical-stage programs investigating potential best-in-class injectables. By applying Pfizer's deep cardiometabolic experience, manufacturing capabilities, and clinical expertise to the advancement of Metsera’s portfolio, we aim to reshape the treatment landscape with more effective, better-tolerated, and convenient medicines. We expect to close this deal in the fourth quarter, subject to satisfaction of customary closing conditions, receipt of regulatory approvals and Metsera’s shareholders' approval. Learn more about today’s announcement: https://lnkd.in/g3FP7ra3 When we are focused and disciplined, Pfizer excels at advancing breakthroughs that change patients’ lives. #Metsera
-
Pfizer is proud to have been named by FastCompany as one of the Best Workplaces for Innovators 2025. #FCBestWorkplaces
Today, I am proud to share that Pfizer has been named to Fast Company's 2025 Best Workplaces for Innovators List. This award is a powerful affirmation of our culture that encourages bold thinking, deep collaboration, and a relentless pursuit of breakthroughs that change patients’ lives. At Pfizer, innovation is not just encouraged––it is embedded in everything we do, driving us to embrace disruption as a catalyst for progress. This mindset is reflected in a deep investment and focus on AI, strong digitally fluent talent, and our commitment to reinventing how we work. It comes to life in initiatives like our digital-first oncology strategy that leverages AI to tackle one of the greatest challenges of our lifetimes, and the launch of our AI-powered digital health experience, #HealthAnswersbyPfizer, that provides up to date, relevant answers to consumers' health and wellness questions. Being named among the best workplaces for innovators underscores our drive to push the boundaries of what is possible to deliver the next breakthrough. To our talented teams: thank you for the creativity, rigor, and dedication you bring each day––this recognition belongs to you! #FCBestWorkplaces
-
-
Below are some highlights from our Q2 2025 #earnings report. Check out the full details from today’s presentation here: https://lnkd.in/eQJhJ9sw
-
Technology meets purpose in this powerful conversation on AI’s role in patient care with Lidia Fonseca and Dr. Sue Desmond-Hellmann. #ThePowerofKnowing.
In the latest episode of #ThePowerofKnowing series, I had the privilege of speaking with Dr. Sue Desmond-Hellmann about how AI is transforming health outcomes by enhancing disease identification, enabling personalized treatment, and accelerating drug development. Sue’s experience as a renowned oncologist, scientist, and former CEO of the Gates Foundation brings rich insights to our conversation. A few key learnings: AI is an accelerant to help us drive faster, smarter breakthroughs; responsibility and ethics play a key role in successful outcomes; and I loved Sue’s advice about “learning to learn” to cope with a rapidly evolving world. Sue also spoke about how AI can help us understand why certain cancers, like colon cancer, are appearing in younger patients, speeding up epidemiological work and diagnosis, and creating the possibility to develop treatments with improved targeting. These considerations are essential to Pfizer’s work in oncology, consumer health, and cross-industry partnerships, which we also discussed in this conversation. 🎥 Watch this episode of #ThePowerofKnowing to join the conversation: https://lnkd.in/eMErKR7v.